The present invention relates to novel compounds of formula I wherein the variable groups are as defined in the claims or a pharmaceutically acceptable acid addition salt thereof. The compounds of the invention are NK2 antagonists.
本发明涉及一种新型的I式化合物,其中变量基团如权利要求所定义或其药学上可接受的酸加成盐。本发明的化合物是NK2受体
拮抗剂。